CBAF312X2205: A Multi-Centre, Double-Blind, Placebo Controlled, Proof of Concept Study to Evaluate the Efficacy and Tolerability of BAF312 in Patients with Polymyositis

Project: Research project

Project Details

StatusFinished
Effective start/end date6/26/15 → 3/31/17

Funding

  • Novartis Pharmaceuticals Corporation (CBAF312X2205)